Haitian Creole
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
diabetes mellitus type 2/carbohydrate
Lyen an sove nan clipboard la
Paj 1 soti nan 18 rezilta yo
Phenyl-1,2,4-oxadiazolone derivatives, processes for their preparation and methods for their use as pharmaceuticals
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
FIELD OF THE INVENTION
The present invention relates generally to pharmaceutical compositions for the treatment of metabolic disorders and the diseases and the physiological manifestations resulting therefrom. More specifically, the present invention relates to phenyl- and
Heterocyclic amide derivatives for the treatment of diabetes and other diseases
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION
Type 2 diabetes, also referred to as non-insulin dependent diabetes mellitus (NIDDM), afflicts between 80 and 90% of all diabetic patients in developed countries. In the United States alone, approximately 15 million people, and more than 100 million worldwide, are
Method and apparatus for computer modeling diabetes
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
COPYRIGHT NOTICE
A portion of the disclosure of the patent document contains material that is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent document of the patent disclosure, as it appears in the Patent and Trademark
7-azaindoles, pharmaceutical compositions and their therapeutic applications
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a continuation of International Patent Application No. PCT/EP2005/009269 filed on Aug. 27, 2005 which is incorporated herein by reference in its' entirety which also claims the benefit of priority of European Patent Application No.
Method for treatment of diabetes by a small molecule inhibitor for GRK5
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is related to compound capable of modulating the activity and/or expression of certain protein kinases thereby enhancing the expression and/or release of insulin. The invention is further related to methods of identifying
Compositions and methods to lower glycohemoglobin levels
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
TECHNICAL FIELD
This invention relates to glycohemoglobin levels, and more particularly to a compositions and methods to lower glycohemoglobin levels.
BACKGROUND
The glucose absorbed following the ingestion of glucose-containing foods is largely responsible for a rise in the circulating glucose
Bicyclic heterocycles for the treatment of diabetes and other diseases
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION
Type 2 diabetes, also referred to as non-insulin dependent diabetes mellitus (NIDDM), afflicts between 80 and 90% of all diabetic patients in developed countries. In the United States alone, approximately 15 million people, and more than 100 million worldwide, are
Heterocyclic derivatives for the treatment of diabetes and other diseases
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION
Type 2 diabetes, also referred to as non-insulin dependent diabetes mellitus (NIDDM), afflicts between 80 and 90% of all diabetic patients in developed countries. In the United States alone, approximately 15 million people, and more than 100 million worldwide, are
Substituted heterocycles for the treatment of diabetes and other diseases
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION
Type 2 diabetes, also referred to as non-insulin dependent diabetes mellitus (NIDDM), afflicts between 80 and 90% of all diabetic patients in developed countries. In the United States alone, approximately 15 million people, and more than 100 million worldwide, are
Imidazolidinedione derivatives for the treatment of diabetes and other diseases
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION
Type 2 diabetes, also referred to as non-insulin dependent diabetes mellitus (NIDDM), afflicts between 80 and 90% of all diabetic patients in developed countries. In the United States alone, approximately 15 million people, and more than 100 million worldwide, are
Thiazolidinedione derivatives for the treatment of diabetes and other diseases
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION
Type 2 diabetes, also referred to as non-insulin dependent diabetes mellitus (NIDDM), afflicts between 80 and 90% of all diabetic patients in developed countries. In the United States alone, approximately 15 million people, and more than 100 million worldwide, are
Peptides, derivatives and analogs thereof, and methods of using same
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
REFERENCE TO GOVERNMENT GRANT
Not Applicable.
JOINT RESEARCH AGREEMENT
Not Applicable.
FIELD OF THE INVENTION
The present invention provides peptides and analogs thereof and methods of using them for treating type 1 diabetes mellitus, type 2 diabetes mellitus and other conditions. The invention
Peptides, derivatives and analogs thereof, and methods of using same
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
REFERENCE TO GOVERNMENT GRANT
Not Applicable.
JOINT RESEARCH AGREEMENT
Not Applicable.
FIELD OF THE INVENTION
The present invention provides peptides and analogs thereof and methods of using them for treating type 1 diabetes mellitus, type 2 diabetes mellitus and other conditions. The invention
Peptides, derivatives and analogs thereof, and methods of using same
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
REFERENCE TO GOVERNMENT GRANT
NOT APPLICABLE.
JOINT RESEARCH AGREEMENT
NOT APPLICABLE.
FIELD OF THE INVENTION
The present invention provides peptides and analogs thereof and methods of using them for treating type 1 diabetes mellitus, type 2 diabetes mellitus and other conditions. The invention
Peptides, derivatives and analogs thereof, and methods of using same
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
C. REFERENCE TO GOVERNMENT GRANT
Not Applicable.
D. JOINT RESEARCH AGREEMENT
Not Applicable.
E. FIELD OF THE INVENTION
The present invention provides peptides and analogs thereof and methods of using them for treating type 1 diabetes mellitus, type 2 diabetes mellitus and other conditions. The
Baz done ki pi konplè remèd fèy medsin te apiye nan syans
- Travay nan 55 lang
- Geri èrbal te apiye nan syans
- Remèd fèy rekonesans pa imaj
- Kat entèaktif GPS - tag zèb sou kote (vini byento)
- Li piblikasyon syantifik ki gen rapò ak rechèch ou an
- Search remèd fèy medsin pa efè yo
- Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive
Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye
